Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of ...
Swedish Orphan Biovitrum AB, or Sobi, SE:SOBI on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. CTIC in a deal valued at $1.7 billion. Shares of ...
Swedish Orphan Biovitrum AB agreed to buy US biotech CTI BioPharma Corp., which develops therapies for blood-related cancers, in a deal valued at $1.7 billion. Sobi shares plunged as much as 17% in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback